+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ACHYUT ACHYUT

Achyut Healthcare Share Price

₹5.18 +0.2 (4.02%)
48.41% Fall from 52W High

14 Oct, 2026 11:31 AM (IST)

Achyut Healthcare live price: ₹5.18. It opened at ₹5 vs previous close ₹5; intraday high/low: ₹5/₹5. The 50 & 200 DMA stand at ₹6.50/₹6.20.

Achyut Healthcare Performance

  • Today's Low
  • ₹5
  • Today's High
  • ₹5
  • 52 Week Low
  • ₹5
  • 52 Week High
  • ₹10
  • Open Price₹5
  • Previous Close₹5
  • Volume34,712
  • 50 DMA₹6.50
  • 100 DMA₹6.50
  • 200 DMA₹6.20

Achyut Healthcare Chart

Investment Returns

  • Over 1 Month -25.36%
  • Over 3 Month -34.43%
  • Over 6 Month -6.5%
  • Over 1 Year -14.38%

Smart Investing Starts Here Start SIP with Achyut Healthcare for Steady Growth!

Invest Now

Achyut Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 384.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 125
  • P/B Ratio
  • 3.6
  • Average True Range
  • 0.4
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.4
  • RSI
  • 14.25
  • MFI
  • 4.76

Latest Stock News Updates

Achyut Healthcare Ltd - 543499 - Announcement under Regulation 30 (LODR)-Change in Management

Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mr. Rutvik S. Thakkar (DIN: 09387486) as a Independent Director of the Company.

Achyut Healthcare Ltd - 543499 - Announcement under Regulation 30 (LODR)-Change in Management

Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mrs. Sonu Lalitkumar Jain (DIN : 09387661) as a Independent Director of the Company.

Achyut Healthcare Ltd - 543499 - Announcement under Regulation 30 (LODR)-Change in Management

Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mr. Jigen J. Modi (DIN : 03355555) as a Managing Director of the Company.

Achyut Healthcare Financials

Achyut Healthcare Technicals

EMA & SMA

Current Price
₹5.18
+ 0.2 (4.02%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹6.00
  • 50 Day
  • ₹6.50
  • 100 Day
  • ₹6.50
  • 200 Day
  • ₹6.20

Resistance and Support

5.09 Pivot Speed
  • R3 5.50
  • R2 5.40
  • R1 5.20
  • S1 4.90
  • S2 4.80
  • S3 4.60

Achyut Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-13 Quarterly Results
2026-05-27 Audited Results
2026-01-21 Quarterly Results & Preferential issue (Revised)
2025-10-16 Half Yearly Results
2025-09-02 A.G.M.
Date Purpose Remarks
2024-12-10 Split Stock split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2024-12-10 Bonus Bonus issue in the ratio of 4:10 of Re. 1/-.
2023-04-25 Bonus Bonus issue in the ratio of 1:2 of Rs. 10/-.

Achyut Healthcare Shareholding Pattern

47.47%
47.4%
5.13%
0%

About Achyut Healthcare

Achyut Healthcare is engaged in trading and marketing a wide range of formulations. The Company has manufacturing facilities under development along with trading and related activities extending to the global market. View More
  • NSE Symbol
  • ACHYUT
  • BSE Symbol
  • 543499
  • Executive Director,Managing Director,Chief Financial Officer
  • Jigen Jagdishbhai Modi
  • ISIN
  • INE0K1401020

Similar Stocks to Achyut Healthcare

Achyut Healthcare FAQs

Achyut Healthcare share price is ₹5 As on 14 October, 2026 | 11:19

The Market Cap of Achyut Healthcare is ₹125 Cr As on 14 October, 2026 | 11:19

The P/E ratio of Achyut Healthcare is 384.6 As on 14 October, 2026 | 11:19

The PB ratio of Achyut Healthcare is 3.6 As on 14 October, 2026 | 11:19

The 52 week High & Low of Achyut Healthcare is ₹10/₹4.7 respectively As on 14 October, 2026 | 11:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23